Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab.

Yazdani-Biuki B, Stelzl H, Brezinschek HP, Hermann J, Mueller T, Krippl P, Graninger W, Wascher TC.

Eur J Clin Invest. 2004 Sep;34(9):641-2. No abstract available.

PMID:
15379764
2.

[TNF-alpha and insulin-resistance: metabolic effects of in vivo therapeutic blockade].

Ursini F.

Reumatismo. 2009 Oct-Dec;61(4):254-9. Review. Italian.

3.

Infliximab and insulin resistance.

Ursini F, Naty S, Grembiale RD.

Autoimmun Rev. 2010 Jun;9(8):536-9. doi: 10.1016/j.autrev.2009.12.014. Epub 2010 Jan 7. Review.

PMID:
20060507
4.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

5.

TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad.

Knobler H, Schattner A.

QJM. 2005 Jan;98(1):1-6. Review.

PMID:
15625348
6.

Androgens, insulin resistance and vascular disease in men.

Kapoor D, Malkin CJ, Channer KS, Jones TH.

Clin Endocrinol (Oxf). 2005 Sep;63(3):239-50. Review.

PMID:
16117808
7.

[Antibodies directed against the insulin receptor and insulin-resistant diabetes].

Van Obberghen E, Kahn CR.

Journ Annu Diabetol Hotel Dieu. 1980 May:283-96. Review. French. No abstract available.

PMID:
6995674
8.

The insulin system: influence of antioxidants.

Preuss HG.

J Am Coll Nutr. 1998 Apr;17(2):101-2. Review. No abstract available.

PMID:
9550450

Supplemental Content

Support Center